MENU
+Compare
ANIP
Stock ticker: NASDAQ
AS OF
Dec 3 closing price
Price
$82.67
Change
+$0.55 (+0.67%)
Capitalization
1.86B

ANIP ANI Pharmaceuticals Forecast, Technical & Fundamental Analysis

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals... Show more

ANIP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ANIP with price predictions
Nov 28, 2025

ANIP in upward trend: price may jump up because it broke its lower Bollinger Band on November 17, 2025

ANIP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 29 cases where ANIP's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ANIP's RSI Indicator exited the oversold zone, of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 47 cases where ANIP's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 28, 2025. You may want to consider a long position or call options on ANIP as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ANIP just turned positive on November 28, 2025. Looking at past instances where ANIP's MACD turned positive, the stock continued to rise in of 60 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ANIP advanced for three days, in of 299 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

ANIP moved below its 50-day moving average on November 05, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ANIP crossed bearishly below the 50-day moving average on October 31, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANIP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ANIP entered a downward trend on November 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ANIP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.671) is normal, around the industry mean (17.312). P/E Ratio (51.673) is within average values for comparable stocks, (72.847). ANIP's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.956). ANIP has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (2.054) is also within normal values, averaging (55.504).

View a ticker or compare two or three
ANIP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ANIP is expected to report earnings to $2.04 per share on February 26

ANI Pharmaceuticals ANIP Stock Earnings Reports
Q4'25
Est.
$2.04
Q3'25
Beat
by $0.28
Q2'25
Beat
by $0.40
Q1'25
Beat
by $0.36
Q4'24
Beat
by $0.18
The last earnings report on November 07 showed earnings per share of $2.04, beating the estimate of $1.76. With 390.94K shares outstanding, the current market capitalization sits at 1.86B.
A.I. Advisor
published General Information

General Information

a manufacturer of branded and generic prescription pharmaceuticals

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
210 Main Street West
Phone
+1 218 634-3500
Employees
642
Web
https://www.anipharmaceuticals.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FFNIX14.26N/A
N/A
Fidelity Advisor Asset Manager 40% I
MLRTX10.73N/A
N/A
NYLI Winslow Large Cap Growth Class R2
GSATX36.77N/A
N/A
Goldman Sachs Small Cp Val Insghts A
BCAIX37.47N/A
N/A
Boston Common ESG Impact Intl
JEGRX17.66N/A
N/A
Janus Henderson Global Sust Eq R

ANIP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIP has been loosely correlated with ORGO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIP jumps, then ORGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIP
1D Price
Change %
ANIP100%
-2.72%
ORGO - ANIP
47%
Loosely correlated
-0.98%
AMRX - ANIP
32%
Poorly correlated
-2.48%
SNDL - ANIP
31%
Poorly correlated
+1.79%
PRGO - ANIP
29%
Poorly correlated
-1.59%
ANIK - ANIP
29%
Poorly correlated
-3.33%
More

Groups containing ANIP

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIP
1D Price
Change %
ANIP100%
-2.72%
Pharmaceuticals: Generic
industry (213 stocks)
36%
Loosely correlated
+0.76%